Cargando…

Inflammatory changes and the prostate

Detalles Bibliográficos
Autor principal:	Soloway, Mark S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2013
Materias:	Urological Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974486/ https://www.ncbi.nlm.nih.gov/pubmed/24707359 http://dx.doi.org/10.5173/ceju.2013.03.art3

Ejemplares similares

Bladder cancer – How to improve?
por: Soloway, Mark S.
Publicado: (2013)

Pathology examination cannot be done without a urologist's help
por: Soloway, Mark S.
Publicado: (2014)

Salvage open radical prostatectomy after failed radiation therapy: a single center experience
por: Gorin, Michael A., et al.
Publicado: (2011)

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)
por: Witjes, J Alfred, et al.
Publicado: (2013)

Resveratrol in prostate diseases
por: Salagierski, Maciej
Publicado: (2013)

Obesity and prostate cancer research
por: Van den Broeck, Thomas, et al.
Publicado: (2013)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Prostate cancer recurrence – new prognostic factors are needed
por: Wajsman, Zew
Publicado: (2013)

Education concerning carcinoma of prostate and its early detection
por: Dutkiewcz, Sławomir, et al.
Publicado: (2011)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
por: Bancroft, Elizabeth K., et al.
Publicado: (2018)

Outcome of surgery in locally advanced pT3a prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2011)

Complication rates after prostate biopsy according to the number of sampled cores
por: Madej, Adam, et al.
Publicado: (2012)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Unexpected Seed Migration in Prostate Brachytherapy Implants Coincident with Change in Seed Stranding Product
por: Rose, Jim, et al.
Publicado: (2017)

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
por: Uemura, Hirotsugu, et al.
Publicado: (2020)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System
por: da Silva, Anna Carolina Borges, et al.
Publicado: (2023)

Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system
por: Dickinson, Louise, et al.
Publicado: (2013)

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
por: Connell, Shea P., et al.
Publicado: (2019)

Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen ((68)Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological node‐positive extended lymph node dissection
por: Huits, Thijs H., et al.
Publicado: (2020)

The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression
por: Wollersheim, Barbara M., et al.
Publicado: (2019)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

Optimising the number of cores for magnetic resonance imaging‐guided targeted and systematic transperineal prostate biopsy
por: Hansen, Nienke L., et al.
Publicado: (2019)

Patient‐reported ‘ever had’ and ‘current’ long‐term physical symptoms after prostate cancer treatments
por: Gavin, Anna T., et al.
Publicado: (2015)

An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)
por: Carles, Joan, et al.
Publicado: (2018)

The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy
por: Fryczkowski, Mieczysław, et al.
Publicado: (2011)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life
por: Lane, Athene, et al.
Publicado: (2016)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
por: Zhao, Yi, et al.
Publicado: (2021)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study
por: Thomsen, Frederik B., et al.
Publicado: (2021)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial
por: Müllhaupt, Gautier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0r0gjqnkg82rlhsqdifl04s7vs